Suppression Of Cml Hematopoietic Progenitor Growth Following Bcr/Abl-Kinase Inhibition By Imatinib Mesylate Does Not Result From Mapk Inhibition And Is Synergistically Enhanced Following Inhibition Of Mapk Activity.
BLOOD（2002）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要